NewCardio 3D ECG platform nets possible patent

Kaitlyn Dmyterko | | Health Imaging | Screening
The U.S. Patent and Trademark Office (USPTA) has granted a notice of allowance to cardiac diagnostic technology provider NewCardio for its urgent care solution Cardio3KG.

Cardio3KG uses algorithms to assess electrical activity in the heart to extract 3D information from 12-lead ECG signals to pinpoint disease and chronic conditions.

According to the Santa Clara, Calif.-based company, use of Cardio3KG will enable a more rapid diagnosis of acute coronary syndromes as patients arrive at the emergency department.

If issued, the patent will be the second for products on NewCardio’s 3D ECG technology platform.

Kaitlyn Dmyterko

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.